Read, understand and consent to the blog's DISCLAIMER here before proceeding to read the article
This is one big step towards protecting exclusivity of VASCEPA. The patent claims on TG & Apo-B reduction, LDL neutrality as well as non-HDL, Lp-Pla2 reduction. This patent is for the marine(500-2000mg/dl TG) indication.
Marine Patent claims-> Link